Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 667
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01590901 | Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects | ||
| NCT03033069 | A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD) | ||
| NCT01779401 | Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients | ||
| NCT00664014 | A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia | ||
| NCT04464564 | Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type | ||
| NCT00321516 | Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder | ||
| NCT04719637 | Clinical Study of an Ultrasound Renal Denervation System in Patients With Heart Failure | ||
| NCT02446132 | Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type | ||
| NCT05326347 | A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia | ||
| NCT00666965 | A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients | ||
| NCT03931369 | Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) | ||
| NCT02069119 | A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF) | ||
| NCT00362271 | Aripiprazole and Effexor XR Drug Interaction Study | ||
| NCT01631825 | A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients | ||
| NCT05650320 | To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with AD | ||
| NCT00885079 | Confirmatory Study of OPC-12759 Ophthalmic Suspension | ||
| NCT02250170 | Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor | ||
| NCT01810783 | Brexpiprazole in Patients With Schizophrenia | ||
| NCT02859402 | Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas | ||
| NCT05190744 | Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration | ||
| NCT01628965 | A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients | ||
| NCT02225067 | Comparison Study Between C13-CAC Breath Test and 24-hour Gastric pH Monitoring | ||
| NCT01214421 | Tolvaptan Extension Study in Participants With ADPKD | ||
| NCT01095016 | A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients | ||
| NCT03839251 | Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients | ||
| NCT01418339 | Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder | ||
| NCT02108288 | Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers | ||
| NCT03386851 | Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder | ||
| NCT05363839 | To Assess the Safety, Tolerability and Pharmacokinetics of ACH-000029 in Healthy Subjects | ||
| NCT03420222 | Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder | ||
| NCT03487770 | Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder | ||
| NCT02435836 | A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia | ||
| NCT01423916 | Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder | ||
| NCT01782833 | Pletaal SR Post Marketing Observational Study | ||
| NCT00292409 | A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices | ||
| NCT01702181 | A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis | ||
| NCT00479336 | A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema | ||
| NCT02472652 | Aripiprazole, Abilify Maintena Collaborative Clinical Protocol | ||
| NCT01418352 | Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD) | ||
| NCT02934932 | A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD | ||
| NCT01360632 | Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial) | ||
| NCT01026584 | Efficacy and Safety of Aripiprazole in First Episode Psychosis | ||
| NCT05615363 | A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF]) | ||
| NCT02168920 | Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type | ||
| NCT02085460 | A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer | ||
| NCT00361790 | Aripiprazole and Lexapro Drug Interaction Study | ||
| NCT03902574 | Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg | ||
| NCT01048788 | A Trial of OPC-41061 in Patients With Hepatic Edema - Investigation of the Safety of Treatment at 7.5 mg Beyond 7 Days and of the Effect of Dose Escalation to 15 mg | ||
| NCT00071331 | EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan | ||
| NCT06757764 | The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis |
